Profiling Insulin Like Factor 3 (INSL3) Signaling in Human Osteoblasts

Background Young men with mutations in the gene for the INSL3 receptor (Relaxin family peptide 2, RXFP2) are at risk of reduced bone mass and osteoporosis. Consistent with the human phenotype, bone analyses of Rxfp2 −/− mice showed decreased bone volume, alterations of the trabecular bone, reduced mineralizing surface, bone formation, and osteoclast surface. The aim of this study was to elucidate the INSL3/RXFP2 signaling pathways and targets in human osteoblasts. Methodology/Principal Findings Alkaline phosphatase (ALP) production, protein phosphorylation, intracellular calcium, gene expression, and mineralization studies have been performed. INSL3 induced a significant increase in ALP production, and Western blot and ELISA analyses of multiple intracellular signaling pathway molecules and their phosphorylation status revealed that the MAPK was the major pathway influenced by INSL3, whereas it does not modify intracellular calcium concentration. Quantitative Real Time PCR and Western blotting showed that INSL3 regulates the expression of different osteoblast markers. Alizarin red-S staining confirmed that INSL3-stimulated osteoblasts are fully differentiated and able to mineralize the extracellular matrix. Conclusions/Significance Together with previous findings, this study demonstrates that the INSL3/RXFP2 system is involved in bone metabolism by acting on the MAPK cascade and stimulating transcription of important genes of osteoblast maturation/differentiation and osteoclastogenesis.

[1]  J. Chau,et al.  Signaling pathways governing osteoblast proliferation, differentiation and function. , 2009, Histology and histopathology.

[2]  T. Franke.  Intracellular Signaling by Akt: Bound to Be Specific , 2008, Science Signaling.

[3]  M. Notelovitz.  Androgen effects on bone and muscle. , 2002, Fertility and sterility.

[4]  R. St-Arnaud.  The direct role of vitamin D on bone homeostasis. , 2008, Archives of biochemistry and biophysics.

[5]  E. Verheyen,et al.  Regulation of Wnt/β‐catenin signaling by protein kinases , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[6]  A. Leask,et al.  Cyclic AMP regulates extracellular matrix gene expression and metabolism in cultured primary rat chondrocytes. , 2009, Matrix biology : journal of the International Society for Matrix Biology.

[7]  V. Echeverria,et al.  Raf inhibition protects cortical cells against β-amyloid toxicity , 2008, Neuroscience Letters.

[8]  G. Haines,et al.  Differential expression of the FAK family kinases in rheumatoid arthritis and osteoarthritis synovial tissues , 2007, Arthritis research & therapy.

[9]  G. Gronowicz,et al.  Transforming growth factor-beta 1 (TGF-β1) prevents the age-dependent decrease in bone formation in human osteoblast/implant cultures , 2005 .

[10]  K. Ng,et al.  Is Wnt signalling the final common pathway leading to bone formation? , 2009, Molecular and Cellular Endocrinology.

[11]  A. Bailey,et al.  Biochemical changes in the collagen of human osteoporotic bone matrix. , 1993, Connective tissue research.

[12]  B. Doble,et al.  GSK-3: tricks of the trade for a multi-tasking kinase , 2003, Journal of Cell Science.

[13]  C. Korgaonkar,et al.  Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52. , 2006, The Journal of biological chemistry.

[14]  M. Zaccolo,et al.  Mutations in the Insulin‐Like Factor 3 Receptor Are Associated With Osteoporosis , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  C. Foresta,et al.  T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane. , 2007, American journal of physiology. Endocrinology and metabolism.

[16]  I. Gorlov,et al.  Suppression of insulin-like3 receptor reveals the role of β-catenin and Notch signaling in gubernaculum development. , 2011, Molecular endocrinology.

[17]  C. Korgaonkar,et al.  Akt Regulates Basal and Induced Processing of NF-κB2 (p100) to p52* , 2006, Journal of Biological Chemistry.

[18]  M. Sporn,et al.  Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro , 1987, The Journal of cell biology.

[19]  R. Terkeltaub,et al.  Proline-rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal-induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytes. , 2004, Arthritis and rheumatism.

[20]  B. Fredholm,et al.  Signalling from adenosine receptors to mitogen-activated protein kinases. , 2003, Cellular signalling.

[21]  S. Nilsson,et al.  Osteopontin: a bridge between bone and blood , 2006, British journal of haematology.

[22]  G. Frühbeck,et al.  The Bone-Adipose Axis in Obesity and Weight Loss , 2008, Obesity surgery.

[23]  R. Gainetdinov,et al.  The Akt-GSK-3 signaling cascade in the actions of dopamine. , 2007, Trends in pharmacological sciences.

[24]  Mone Zaidi,et al.  Skeletal remodeling in health and disease , 2007, Nature Medicine.

[25]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[26]  G. Stein,et al.  Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation. , 1995, The Iowa orthopaedic journal.

[27]  J. Termine.  Cellular activity, matrix proteins, and aging bone , 1990, Experimental Gerontology.

[28]  Klaus Resch,et al.  Phosphorylation of Serine 468 by GSK-3β Negatively Regulates Basal p65 NF-κB Activity* , 2004, Journal of Biological Chemistry.

[29]  A. Lenzi,et al.  Changes in serum insulin-like factor 3 during normal male puberty. , 2006, The Journal of clinical endocrinology and metabolism.

[30]  J. Riancho,et al.  Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study , 2009, Osteoporosis International.

[31]  A. Andersson,et al.  The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men. , 2006, The Journal of clinical endocrinology and metabolism.

[32]  S. Boonen,et al.  Androgens and bone. , 2004, Calcified tissue international.

[33]  Toshihisa Komori,et al.  Regulation of bone development and extracellular matrix protein genes by RUNX2 , 2009, Cell and Tissue Research.

[34]  A. Raucci,et al.  Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways , 2008, Journal of cellular physiology.

[35]  R. Ivell,et al.  Constitutive regulation of the Insl3 gene in rat Leydig cells , 2005, Molecular and Cellular Endocrinology.

[36]  Klaus Resch,et al.  Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. , 2004, The Journal of biological chemistry.

[37]  B. Harbrecht,et al.  Akt-mediated signaling is induced by cytokines and cyclic adenosine monophosphate and suppresses hepatocyte inducible nitric oxide synthase expression independent of MAPK P44/42. , 2011, Biochimica et biophysica acta.

[38]  C. Foresta,et al.  A novel circulating hormone of testis origin in humans. , 2004, The Journal of clinical endocrinology and metabolism.

[39]  R. Ricci,et al.  MAPK signalling in cellular metabolism: stress or wellness? , 2010, EMBO reports.

[40]  C. Foresta,et al.  INSL3 Plays a Role in the Balance between Bone Formation and Resorption , 2009, Annals of the New York Academy of Sciences.

[41]  G. Belinsky,et al.  A New Action of Parathyroid Hormone , 1997, The Journal of Biological Chemistry.

[42]  A. Agoulnik.  Relaxin and related peptides in male reproduction. , 2007, Advances in experimental medicine and biology.

[43]  C. Foresta,et al.  New Roles for INSL3 in Adults , 2009, Annals of the New York Academy of Sciences.

[44]  Yoshikazu Nakamura,et al.  Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance. , 2010, Progress in lipid research.

[45]  J. Wade,et al.  INSL3/RXFP2 Signaling in Testicular Descent , 2009, Annals of the New York Academy of Sciences.